Webinars
Longitudinal plasma proteomics of severe COVID-19
An Olink-sponsored, Science/AAAS webinar, originally broadcast on 18th November 2020, featuring Michael Filbin, M.D., M.Sc., Massachusetts General Hospital, Boston, MA and Arnav Mehta, M.D., Ph.D., Broad Institute of MIT and Harvard, Boston, MA. Click the link below to register and access the on-demand recording of this presentation.
Human immunity to SARS-CoV-2
An Olink Proteomics-hosted webinar, originally broadcast on 5th November 2020, featuring Dr. Prabhu Arunachalam, Ph.D. (Stanford). Click the link below to register and access the on-demand recording of this presentation.
Uncovering novel protein biomarkers in drug discovery and development: Targeting disease diagnosis and drug response monitoring
An Olink Proteomics-sponsored Science/AAAS webinar, originally broadcast on 19th February 2020, featuring Christopher D. Whelan, Ph.D.Biogen Research and Early Development, Cambridge, MA. and Simina Ticau, Ph.D. Alnylam Pharmaceuticals, Cambridge, MA. Click the link below to register and access the on-demand recording of these presentations.
Emerging liquid biopsy biomarkers: Predicting response and resistance to cancer immunotherapy
An Olink Proteomics-sponsored Science/AAAS webinar, originally broadcast on 9th October 2019, featuring Genevieve Boland, M.D., Ph.D., FACS Massachusetts General Hospital, Boston, MA and Evert Jan Van Limbergen, M.D., Ph.D.Maastro Clinic Maastricht, The Netherlands. Click the link below to register and access the on-demand recording of these presentations.
Protein biomarkers and cardiovascular /cardiometabolic disease: Better prediction, deeper understanding
An Olink Proteomics-sponsored Science/AAAS webinar , originally broadcast on 22nd May 2019 , featuring Professor Robert Gerszten, M.D. (Beth Israel Deaconess Medical School, Boston) and Dr. Michiel J. Bom, M.D. (VU University Medical Center Amsterdam). Click the link below to register and access the on-demand recording of these presentations.
A systems biology approach to unravelling the complexities of immune system development and function
An Olink Proteomics-sponsored Science/AAAS webinar , originally broadcast on 5th December 2018 , featuring Associate Professor Petter Brodin (Karolinska Institute, Stockholm) & Professor Yueh-hsiu Chien (Stanford University , CA). Click the link below to register and access the on-demand recording of these presentations.
Driving precision medicine through biostatistics: Translating multiomics biomarker data into breakthrough knowledge
An Olink Proteomics-sponsored Science/AAAS webinar , originally broadcast on 3rd October 2018 , featuring Dr. Eric Fauman (Pfizer, USA) & Dr. Jasper Tromp (University Medical Centre Groningen, The Netherlands).. Click the link below to register and access the on-demand recording of these presentations.
Getting under the skin of dermatological diseases using protein biomarkers
An Olink Proteomics-sponsored Science/AAAS webinar , originally broadcast on 22nd August 2018 , featuring Professors Emma Guttman (Icahn School of Medicine at Mount Sinai New York,) and Professor James G. Krueger (The Rockefeller University New York). Click the link below to register and access the on-demand recording of these presentations.
Unlocking the elusive mind: The role of protein biomarkers in understanding neurodegenerative disease
An Olink Proteomics-sponsored Science/AAAS webinar , originally broadcast on 1st November 2017 , featuring Professors Henrik Zetterberg & Kaj Blennow (Gothenburg University) & Professor Douglas Galasko (University of California, San Diego). Click the link below to register and access the on-demand recording of these presentations.
Proteogenomic strategies to advance drug development and precision medicine
An Olink Proteomics-sponsored Science/AAAS webinar , originally broadcast on September 6, 2017, featuring Professor Ulf Gyllensten (Uppsala University) and Dr. Anders Mälarstig (Pfizer, Stockholm). Click the link below to register and access the on-demand recording of these presentations.
Introduction to Olink’s Multiplex panels: an innovative tool for protein biomarker research
This recorded seminar provides an introduction to PEA technology and its applications. Olink’s panels provide a high-throughput multiplex immunoassay product which allows simultaneous detection of 92 protein biomarkers in 90 samples simultaneously using only 1 µL of sample without compromising assay performance.
Strong impact of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs
In this recorded webinar, Professor Ulf Gyllensten from Uppsala University presents a large-scale study where 92 protein biomarkers are analyzed in 1,005 healthy individuals from a unique population using an Olink panel focused on oncology. This study reveals that genetics and lifestyle factors are strong influencers of protein levels in the bloodstream and suggests the establishment of personalized cut off values. Personally normalized plasma protein profiles can open up new possibilities of assessing protein biomarkers for prediction, prognosis or targeting different diseases.